235 related articles for article (PubMed ID: 28509722)
1. Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.
Giles TD; Cockcroft JR; Pitt B; Jakate A; Wright HM
J Hypertens; 2017 Sep; 35(9):1758-1767. PubMed ID: 28509722
[TBL] [Abstract][Full Text] [Related]
2. Fixed-dose combination therapy of nebivolol and valsartan for the treatment of hypertension.
Sander GE; Fernandez C; Giles TD
Expert Rev Cardiovasc Ther; 2016; 14(5):563-72. PubMed ID: 26986445
[TBL] [Abstract][Full Text] [Related]
3. Additivity of nebivolol/valsartan single-pill combinations versus other single-pill combinations for hypertension.
Ishak J; Rael M; Punzi H; Gradman A; Anderson LM; Patel M; Ali S; Ferguson W; Neutel J
J Clin Hypertens (Greenwich); 2018 Jan; 20(1):143-149. PubMed ID: 29105958
[TBL] [Abstract][Full Text] [Related]
4. Nebivolol/Valsartan: A Novel Antihypertensive Fixed-Dose Combination Tablet.
Battise D; Boland CL; Nuzum DS
Ann Pharmacother; 2019 Apr; 53(4):402-412. PubMed ID: 30449127
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of nebivolol-valsartan single-pill combination in obese and nonobese patients with hypertension.
Mende CW; Giles TD; Bharucha DB; Ferguson WG; Mallick M; Patel MD
J Clin Hypertens (Greenwich); 2017 Jun; 19(6):632-639. PubMed ID: 28075064
[TBL] [Abstract][Full Text] [Related]
6. Correlations of plasma renin activity and aldosterone concentration with ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, in hypertension.
Giles TD; Bakris G; Oparil S; Weber MA; Li H; Mallick M; Bharucha DB; Chen C; Ferguson WG;
J Am Soc Hypertens; 2015 Nov; 9(11):845-54. PubMed ID: 26362831
[TBL] [Abstract][Full Text] [Related]
7. A Single-Center, Open-Label, 3-Way Crossover Trial to Determine the Pharmacokinetic and Pharmacodynamic Interaction Between Nebivolol and Valsartan in Healthy Volunteers at Steady State.
Chen CL; Desai-Krieger D; Ortiz S; Kerolous M; Wright HM; Ghahramani P
Am J Ther; 2015; 22(5):e130-40. PubMed ID: 25853236
[TBL] [Abstract][Full Text] [Related]
8. Nebivolol/valsartan combination for the treatment of hypertension: a review.
Wang SJ; Sander GE
Future Cardiol; 2021 Jul; 17(4):573-583. PubMed ID: 33064027
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
[TBL] [Abstract][Full Text] [Related]
10. Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertension.
Sander GE; Giles TD
Expert Opin Pharmacother; 2015 Apr; 16(5):763-70. PubMed ID: 25747524
[TBL] [Abstract][Full Text] [Related]
11. Ambulatory 24-hour cardiac oxygen consumption and blood pressure-heart rate variability: effects of nebivolol and valsartan alone and in combination.
Izzo JL; Khan SU; Saleem O; Osmond PJ
J Am Soc Hypertens; 2015 Jul; 9(7):526-35. PubMed ID: 26116459
[TBL] [Abstract][Full Text] [Related]
12. Nebivolol/valsartan: Fixed-dose combination for treatment of hypertension.
Paton DM
Drugs Today (Barc); 2017 Jan; 53(1):19-26. PubMed ID: 28387384
[TBL] [Abstract][Full Text] [Related]
13. Byvalson--a beta blocker/ARB combination for hypertension.
Med Lett Drugs Ther; 2016 Sep; 58(1503):115-7. PubMed ID: 27603961
[No Abstract] [Full Text] [Related]
14. Comparative beneficial effects of nebivolol and nebivolol/valsartan combination against mitochondrial dysfunction in angiotensin II-induced pathology in H9c2 cardiomyoblasts.
Gul R; Alsalman N; Bazighifan A; Alfadda AA
J Pharm Pharmacol; 2021 Oct; 73(11):1520-1529. PubMed ID: 34453839
[TBL] [Abstract][Full Text] [Related]
15. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
[TBL] [Abstract][Full Text] [Related]
16. Nebivolol/Valsartan (Byvalson) for Hypertension.
Lamberton NH; Copenhaver AM
Am Fam Physician; 2018 Jan; 97(2):124-125. PubMed ID: 29365224
[No Abstract] [Full Text] [Related]
17. Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial.
Lewin A; Punzi H; Luo X; Stapff M
Clin Ther; 2013 Feb; 35(2):142-52. PubMed ID: 23332366
[TBL] [Abstract][Full Text] [Related]
18. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
Frampton JE; Scott LJ
Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety of nebivolol and valsartan combination therapy in patients with hypertension: an open-label, single-arm, multicenter study.
Neutel JM; Giles TD; Punzi H; Weiss RJ; Li H; Finck A
J Am Soc Hypertens; 2014 Dec; 8(12):915-20. PubMed ID: 25492835
[TBL] [Abstract][Full Text] [Related]
20. Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.
Tykarski A; Widecka K; Narkiewicz K; Wożakowska-Kapłon B; Gaciong Z; Grajek S; Grodzicki T; Januszewicz A; Wolf J; Prejbisz A; Kostka-Jeziorny K; Filipiak KJ
Kardiol Pol; 2017; 75(12):1357-1367. PubMed ID: 29251761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
